Platform screens up to 10 billion compounds in hours, delivering wet-lab-ready candidates in weeks without requiring 3D ...
Persistent Launches AI-Powered Generative Molecules and Virtual Screening Solution Powered by NVIDIA
SANTA CLARA, Calif. and PUNE, India, March 17, 2026 /PRNewswire/ -- Persistent Systems (BSE: 533179) (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader, today ...
ABSTRACT: Human alpha-tubulin acetyltransferase 1 (h-αTAT1) is a GNAT-family enzyme responsible for acetylating lysine 40 of α-tubulin, a modification critical for microtubule stability and cellular ...
Researchers in China have unveiled a new AI framework that could accelerate the discovery of new medicines. DrugCLIP can scan millions of potential drug compounds against thousands of protein targets ...
This article and associated images are based on a poster originally authored by Lin Chen, Vincent Blay, Pedro J. Ballester and Douglas R. Houston and presented at ELRIG Drug Discovery 2025 in ...
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. No ...
Groundbreaking care model drives early disease detection for one in every four participants, with 81 percent reporting they would choose ReperioCare™ over traditional in-person appointments PORTLAND, ...
Amazing work as always! I was curious about some of the practical details behind the virtual screening pipeline used in your TYK2 experiments. Specifically, how was the HLL library screen implemented?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results